(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
@ $8.06
Utstedt: 14 feb 2024 @ 21:17
Avkastning: -8.56%
Forrige signal: feb 14 - 17:43
Forrige signal:
Avkastning: 0.62 %
Live Chart Being Loaded With Signals
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins...
Stats | |
---|---|
Dagens volum | 805 920 |
Gjennomsnittsvolum | 872 014 |
Markedsverdi | 1.09B |
EPS | $0.320 ( 2024-04-30 ) |
Neste inntjeningsdato | ( $0.0400 ) 2024-06-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 17.14 |
ATR14 | $0.00900 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Hulse William Frank Iv | Sell | 8 896 | Common Stock |
2024-04-08 | Hulse William Frank Iv | Sell | 8 896 | Common Stock |
2024-03-01 | Puhy Dorothy E | Buy | 0 | |
2024-03-01 | Olson Tiffany | Buy | 0 | |
2024-03-13 | Hulse William Frank Iv | Sell | 20 381 | Common Stock |
INSIDER POWER |
---|
97.68 |
Last 95 transactions |
Buy: 35 462 522 | Sell: 808 933 |
Volum Korrelasjon
MiMedx Group Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
AEY | 0.884 |
LULU | 0.881 |
JOAN | 0.867 |
QH | 0.859 |
HUGE | 0.859 |
SBUX | 0.858 |
EZGO | 0.856 |
ALLR | 0.852 |
GOODM | 0.851 |
NVIV | 0.847 |
10 Mest negative korrelasjoner | |
---|---|
HPLTU | -0.9 |
USAP | -0.893 |
PFSW | -0.892 |
CENX | -0.89 |
PMGMU | -0.882 |
MU | -0.882 |
JNCE | -0.88 |
LABP | -0.879 |
IVCB | -0.879 |
QRHC | -0.878 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
MiMedx Group Inc Korrelasjon - Valuta/Råvare
MiMedx Group Inc Økonomi
Annual | 2023 |
Omsetning: | $321.48M |
Bruttogevinst: | $266.84M (83.01 %) |
EPS: | $0.400 |
FY | 2023 |
Omsetning: | $321.48M |
Bruttogevinst: | $266.84M (83.01 %) |
EPS: | $0.400 |
FY | 2022 |
Omsetning: | $267.84M |
Bruttogevinst: | $219.53M (81.96 %) |
EPS: | $-0.270 |
FY | 2021 |
Omsetning: | $258.62M |
Bruttogevinst: | $215.33M (83.26 %) |
EPS: | $-0.0932 |
Financial Reports:
No articles found.
MiMedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.